Identification and characterization of a putative new psychoactive substance, 2-(2-(4-chlorophenyl)acetamido)- 3-methylbutanamide, in Spain
Impacto
Scholar |
Otros documentos de la autoría: Fabregat-Safont, David; Fornís, I.; Ventura, Mireia; Gil, C.; Calzada, N.; Sancho, Juan V; Hernandez, Felix; Ibáñez, Maria
Metadatos
Mostrar el registro completo del ítemcomunitat-uji-handle:10234/9
comunitat-uji-handle2:10234/33596
comunitat-uji-handle3:10234/33597
comunitat-uji-handle4:
INVESTIGACIONEste recurso está restringido
http://dx.doi.org/10.1002/dta.2182 |
Metadatos
Título
Identification and characterization of a putative new psychoactive substance, 2-(2-(4-chlorophenyl)acetamido)- 3-methylbutanamide, in SpainAutoría
Fecha de publicación
2017-02-28Editor
WileyCita bibliográfica
FABREGAT-SAFONT, David; FORNÍS, I.; VENTURA, M.; GIL, C.; CALZADA, N.; SANCHO LLOPIS, Juan Vicente; HERNÁNDEZ HERNÁNDEZ, Félix; IBÁÑEZ MARTÍNEZ, María. Identification and characterization of a putative new psychoactive substance, 2-(2-(4-chlorophenyl)acetamido)- 3-methylbutanamide, in Spain. Drug Testing and Analysis (2017), v. 9, issue 7, p. 1073-1080Tipo de documento
info:eu-repo/semantics/articleVersión de la editorial
http://onlinelibrary.wiley.com/doi/10.1002/dta.2182/epdfVersión
info:eu-repo/semantics/publishedVersionPalabras clave / Materias
Resumen
The term ‘new psychoactive substances’ (NPS) refers to
synthetically changed natural compounds or newly designed
compounds intended to elicit a psychotropic response such as
stimulation, hallucination or sedation ... [+]
The term ‘new psychoactive substances’ (NPS) refers to
synthetically changed natural compounds or newly designed
compounds intended to elicit a psychotropic response such as
stimulation, hallucination or sedation.
According to the European
Monitoring Centre for Drugs and Drug Addiction of the European
Union, more than 560 NPS are currently being monitored, and 98
of these substance were reported for the first time in 2015.
Despite that, there are still many NPS that are not being monitored,
and therefore their health effects are not yet studied. Hence, many
cases of intoxication and death related to NPS have been reported
in the past few years, highlighting the public health risks of these
substances.
One of the challenges of monitoring NPS is the
continuous structural evolution to evade regulation, so when one
substance is banned or controlled, several new compounds replace
it in the market. [-]
Título del proyecto o subvención
Drug tresting and analysis (2017), v. 9, issue 7
Proyecto de investigación
1) Financial support from Generalitat Valenciana (Group of Excellence Prometeo II 2014/023); 2) Ministerio de Economía y Competitividad in Spain (project CTQ2015-65603-P); 3) The authors also acknowledge NPS-Euronet (HOME/2014/JDRUG/AG/DRUG/7086), co-funded by the European Commission; 4) Ministerio de Educación, Cultura y Deporte in Spain for his predoctoral grant (grant FPU15/2033)Derechos de acceso
http://rightsstatements.org/vocab/CNE/1.0/
info:eu-repo/semantics/restrictedAccess
info:eu-repo/semantics/restrictedAccess
Aparece en las colecciones
- IUPA_Articles [306]